SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,321,000 | +40.2% | 81,893 | +43.6% | 0.01% | +25.0% |
Q3 2016 | $3,081,000 | +34.1% | 57,040 | +0.4% | 0.00% | +33.3% |
Q2 2016 | $2,297,000 | +14.9% | 56,836 | -0.2% | 0.00% | 0.0% |
Q1 2016 | $1,999,000 | -33.4% | 56,964 | -14.9% | 0.00% | -25.0% |
Q4 2015 | $3,002,000 | +17.2% | 66,899 | +0.7% | 0.00% | +33.3% |
Q3 2015 | $2,561,000 | -21.5% | 66,419 | -1.4% | 0.00% | -25.0% |
Q2 2015 | $3,262,000 | +95.6% | 67,392 | +42.8% | 0.00% | +100.0% |
Q1 2015 | $1,668,000 | +6.3% | 47,189 | -3.4% | 0.00% | 0.0% |
Q4 2014 | $1,569,000 | -41.6% | 48,835 | -32.4% | 0.00% | -50.0% |
Q3 2014 | $2,685,000 | -35.0% | 72,206 | -33.2% | 0.00% | -33.3% |
Q2 2014 | $4,132,000 | +155.1% | 108,014 | +203.7% | 0.01% | +200.0% |
Q1 2014 | $1,620,000 | +18.8% | 35,561 | +4.0% | 0.00% | 0.0% |
Q4 2013 | $1,364,000 | -10.6% | 34,194 | -1.8% | 0.00% | -33.3% |
Q3 2013 | $1,526,000 | +41.8% | 34,808 | +1.8% | 0.00% | +50.0% |
Q2 2013 | $1,076,000 | – | 34,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |